Bristol-Myers Squibb Company (BMY) Analyst Estimates
▲ Wall Street analysts forecast BMY to rise 5% over the next 12 months.
Avg Price Target
$62.73
+5.5% upside
According to Wall Street analysts, the average 12-month price target for Bristol-Myers Squibb Company (BMY) is $62.73, implying +5.5% upside from the current price of $59.49.